The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eli Lilly (NYSE:LLY) has agreed to acquire Orna Therapeutics, moving into engineered ...

Eli Lilly has signed its second pipeline-building deal in two days, reaching an agreement to buy in vivo CAR-T developer Orna Therapeutics for up to $2.4 billion. Watertown, Massachusetts start-up ...

Merck and Cambridge, Mass.-based Orna Therapeutics announced a collaboration Aug. 16 to develop and commercialize multiple programs, including vaccines and therapeutics in infectious disease and ...

・Orna’s ORN-252 is a clinical trial-ready CAR-T therapy that targets CD19, a critical cell surface protein to treat B cell-driven autoimmune diseases. ・Early studies indicate Orna’s circular RNA ...

Feb 9 (Reuters) - Eli Lilly (LLY.N), opens new tab will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to generate therapies ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for sickle ...

(RTTNews) - Merck (MRK), and Orna Therapeutics on Tuesday announced partnership to advance Orna's circular RNA technology. As per the deal, Orna will receive an upfront payment of $150 million, and ...